<p>Malignant Ovarian Tumors During Pregnancy: A Multicenter Retrospective Analysis</p>
Liya Wang(Jiangsu University), Yu Wang(Northeastern University), Pengming Sun(Fujian Medical University), Shenjiao Huang(Sun Yat-sen University), Jiandong Wang(Beijing Obstetrics and Gynecology Hospital), Xiujie Sheng(Guangzhou Medical University), Yuhong Li(Southwest Jiaotong University), Xiaoxin Ma(China Medical University), Qiming Wang(Hunan Cancer Hospital), Lin Yang(Yangzhou University), Linqing Yang(Affiliated Hospital of Jining Medical University), Tianmin Xu(Second Affiliated Hospital of Jilin University), Chenchen Ren(Third Affiliated Hospital of Zhengzhou University), Ruixia Guo(First Affiliated Hospital of Zhengzhou University), Shuping Zhao(Harvard University)
Cited by 14
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet Oncology|2022|417
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311